Trastuzumab emtansine for HER2-positive advanced breast cancer.
Verma S; Miles D; Gianni L; Krop IE; Welslau M; Baselga J; Pegram M; Oh DY; Diéras V; Guardino E; Fang L; Lu MW; Olsen S; Blackwell K; The New England Journal Of Medicine, 2012, vol. 367, issue 19, p 1783, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation